Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

Researchers believe that the diabetes drug Avandia may cause bone loss and long-term use may speed up osteoporosis. The thinning of the bones is dangerous and could lead to fatal fractures. The study published in the December 2nd issue of Nature Medicine suggests that usage of rosiglitazone in the treatment of type II diabetes may cause osteoporosis.

Read the rest of this entry »

Avandia, a drug used by millions of diabetes patients, may contribute to bone loss, according to a new study conducted in mice.

Read the rest of this entry »

GlaxoSmithKline, the manufacturer of Avandia, has already admitted that Avandia does contribute to bone fractures in women. However, the latest research goes further in understanding the issue, just what is happening to those brittle bones, and what it is that’s making them brittle in the first place.

Read the rest of this entry »

The popular diabetes drug marketed as Avandia may increase bone thinning, a discovery that could help explain why diabetics can have an increased risk of fractures.

Read the rest of this entry »